Skip to content
BOLUS

Fund

General Catalyst

Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.

Operations logged
9
Lead
3
New entries
6
Follow ons
0
Latest operation
22 September 2026
Sectors
Health software, Diagnostics, Biotech

Operations

Date Company Stage Amount Role
22 Sept

Australia, Health software

Series C 340 M$ Lead
15 Sept

United States

Undisclosed 108 M$ Participant
15 Sept

United States

Series B 40 M$ Participant
08 Sept

United States, Health software

Series C 150 M$ Participant
20 Aug

United States

Series D and later 116 M$ Lead
16 Jul

Sweden, Diagnostics

Series C 700 M$ Participant
26 May

France, Diagnostics

Series A 20 M$ Participant
07 Apr

United States, Diagnostics

Series B 97 M$ Participant
17 Dec

United States, Biotech

Series B 130 M$ Lead
Co investors 55 funds crossed

Funds that appeared in the same rounds, in any capacity. Geographies logged: Australia, United States, Sweden, France.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).